This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

GLP-1 Therapy Interruption Increases Cardiovascular Risk in Type 2 Diabetes: Study

GLP-1 Therapy Interruption Increases Cardiovascular Risk in Type 2 Diabetes: Study

A target trial emulation study has found that a 6-month break in GLP-1 drug therapy in patients with type 2 diabetes was associated with a higher risk...
View All

Latest News and Guidelines

Dapagliflozin and Sitagliptin FDC in Indian T2D: 5 Points Clinicians May Like to Know - Dr K Baraneedharan

Dapagliflozin and Sitagliptin FDC in Indian T2D: 5 Points Clinicians May Like to Know - Dr K...

Intensive Glucose Lowering Reduces Vascular Events Across All Age Groups and Diabetes Durations

GLP-1 Receptor Agonists Linked to Higher Depression Risk Than SGLT2 Inhibitors in T2D: Study

Review Finds Mediterranean-Style Diet May Influence Thyroid Disease Risk and Management

Review Finds Mediterranean-Style Diet May Influence Thyroid Disease Risk and Management

More than 25 percent of Older Adults May Discontinue Levothyroxine Under Supervision: JAMA

More than 25 percent of Older Adults May Discontinue Levothyroxine Under Supervision: JAMA

Metformin: Anchoring Potential in GLP-1 RA Care Journey

Metformin: Anchoring Potential in GLP-1 RA Care Journey

Pregnant Women with Controlled GDM Show No Added Obesity Risk in Offspring: Study

Pregnant Women with Controlled GDM Show No Added Obesity Risk in Offspring: Study

View All
X